Abstract
INTRODUCTION. The study of mini-gastric bypass surgery outcomes with different lengths of the biliopancreatic limb is essential for optimizing restrictive and malabsorptive components, as well as for assessing the risk of adverse outcomes such as insufficient weight loss, weight regain, malabsorption, or sarcopenia development. The OBJECTIVE was to evaluate outcomes in patients with morbid obesity with different lengths of the biliopancreatic limb (170 cm and 210 cm). METHODS AND MATERIALS. A prospective cohort study was conducted involving 192 patients divided into two groups using simple randomization. All patients underwent mini-gastric bypass surgery with different lengths of the biliopancreatic limb. Results were assessed 36 months after surgery, analyzing anthropometric indicators, biochemical markers, and complication rates. RESULTS. No statistically significant differences were found between the groups in the main indicators. The median excess weight loss was 81 % in the first group and 80 % in the second. Diabetes remission was achieved in 79.1 % and 81.4 % of patients, respectively. It was noted that the effectiveness of the surgery depends not on the absolute length of the limb but on the ratio of the excluded segment to the total small intestine length. CONCLUSIONS. The study showed no statistically significant differences between the 170 cm and 210 cm biliopancreatic limb lengths regarding major biochemical and clinical indicators. Thus, the study confirms the need for a personalized approach in bariatric surgery.

This publication has 11 references indexed in Scilit: